Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
COLL —
Collegium Pharmaceutical Inc.
CUSIP: 19459J104 · Held by 3 superinvestors · Combined value: $90,371,859
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.1% | $74,883,259 | 1,617,349 | ADD | +18,160 |
| 2 | Third Avenue Management | 1.7% | $9,417,466 | 203,401 | - | - |
| 3 | Ken Griffin | 0.0% | $6,071,134 | 131,126 | REDUCE | -122,374 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +18,160 | +1.1% |
| Ken Griffin | REDUCE | -122,374 | -48.3% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +78,019 | +5.1% |
| Ken Griffin | ADD | +13,344 | +5.6% |
Who Owns COLL? Superinvestor Holdings
Collegium Pharmaceutical Inc. is held by 3 tracked superinvestors, with a combined position value of $90 million . The largest positions are held by Jim Simons (0.1% of portfolio), Third Avenue Management (1.7% of portfolio), Ken Griffin (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 1 reduced or exited.